Dr. Hawkes discusses the closing gap between biologics and oral treatments for psoriasis and provides an update on a new oral IL-23 receptor inhibitor currently in Phase 3 trials.
Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment. Listen to Dr. Song’s full recap on our JCAD Podcast page here.
...